Physician profile
Mini Gopalan
NPI 1720060932
$3,935.88
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,056 · 2020: $929 · 2021: $1,052 · 2022: $682 · 2023: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $504.24 | 2019-2023 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $497.95 | 2019-2023 | Farxiga |
| Glaxosmithkline, LLC. | $389.31 | 2019-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $316.74 | 2019-2023 | Synjardy, Jardiance |
| Sanofi-Aventis U.S. LLC | $262.18 | 2019-2022 | |
| Novo Nordisk INC | $257.92 | 2019-2022 | |
| Amgen INC. | $249.50 | 2019-2020 | |
| Amarin Pharma, INC. | $191.25 | 2019-2021 | |
| Astellas Pharma US INC | $164.02 | 2020-2023 | Veozah, Myrbetriq |
| Pfizer INC. | $128.26 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $121.43 | 2019-2022 | |
| Abbvie INC. | $117.52 | 2021-2022 | |
| Abbott Laboratories | $102.31 | 2021-2023 | Freestyle Libre 3 |
| Eisai INC. | $97.28 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $79.55 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $73.55 | 2019-2023 | Belsomra |
| Allergan, INC. | $69.77 | 2019-2020 | |
| Esperion Therapeutics, INC. | $47.46 | 2020-2021 | |
| Sanofi Pasteur INC. | $43.39 | 2019 | |
| Radius Health, INC. | $36.26 | 2019-2020 | |
| Genzyme Corporation | $34.61 | 2022 | |
| Redhill Biopharma INC. | $34.58 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $28.01 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.41 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.57 | 2021 | |
| Exact Sciences Corporation | $17.31 | 2023 | Cologuard Collection Kit |
| Dexcom, INC. | $15.87 | 2022 | |
| Lundbeck LLC | $15.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mini Gopalan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.